Skip to main content
An official website of the United States government
Email

Transition to Industry Fellowship (T2I)

Scientist working in lab

The NCI Transition to Industry (T2I) Fellowship supports post-doctoral scientists, research fellows, or graduate students from NCI Center for Cancer Research (CCR) labs for 2 years, as they advance an invention toward a regulatory milestone, clinical trials, and subsequent commercialization. The goal of this unique program is to nurture post-doctoral entrepreneurship and industry-focused research training.

Eligibility and Stipend

Eligibility

  • NCI CCR Graduate Students, Post-doctoral fellows or Research Fellows (as long as their current appointment extends beyond the duration of T2I, which is 2 years starting in January)

  • Applicants must also be either an inventor on a patent/patent application or working on a project for which a patent/patent application has been filed *or recommended for filing*

  • Selection into the T2I program will not alter any visa requirements or appointment limits of the candidate

Stipend

  • Standard NCI CCR post-doc salary policies apply

About the T2I Budget

  • While we request that applicants submit a proposed budget in their applications, NCI CCR supports the T2I fellow position plus the standard S&S amount (ex. $26,500 for 2021)

How to Apply

Application Deadline for 2025-2027

November 15

How to Apply

If you are interested in joining the T2I, please complete the application and other required materials using the link below and return to T2I_Fellowship@mail.nih.gov. Please be sure to submit all of the Required Additional Documentation listed in the application for full consideration.

Download and complete

Application and PI Approval Form

About the Program & Training Curriculum

Program Objectives

  • Nurture post-doctoral entrepreneurship and industry-focused research training
  • Accelerate the development of an early stage invention towards commercialization
  • Increase the commercialization potential of NCI inventions

Program Components

T2I fellows spend 80% of their time in their laboratory focused on invention development research, moving a basic science research invention from the “bench to commercialization” and 20% of their time take courses and trainings in business development, entrepreneurship, and small business grantsmanship.

Mentorship

Each trainee will work with his/her laboratory mentor for the 80% laboratory component and with an assigned TTC or SBIR training mentor for the 20% training component. Trainees will form an invention development Committee. Quarterly meetings will be scheduled with the Laboratory Mentor and the T2I Mentoring Team. T2I mentors will include the TTC and SBIR program coordinators, the Technology Transfer Manager handling intellectual property matters for the Principal Investigator of the invention, and an external scientific committee member.

T2I Curriculum by Semester

Yr-1 Winter/Spring Semester Yr-1 Summer/Fall Semester Yr-2 Winter/Spring Semester Yr-2 Summer/Fall Semester

Technology Transfer Ambassadors Program (TTAP) Boot Camp Course

TTC: Work experience on IP, Licensing, Agreement, Due Diligence Skills Training

Lightning Pitch & Poster development: To be presented at the annual Technology Showcase

Mid-Point Presentation to T2I stakeholders

FAES Technology Transfer Course TECH 565:
Biomedical Business Development for Scientists

FAES Electives

List of FAES Elective Courses

Continued internship with SBIR

Technology Transfer University (TTU) Courses

Attend and present at the Technology Showcase

Lead an I-Corps Team through NCI's Advancing Innovations through Mentorship (AIM) Program

SBIR Grantsmanship: (course to be determined and/or work experience in NCI SBIR Development Center/SBIR-I-Corps training (audit) Submission of Final Report and Final Presentation to T2I stakeholders

 

Administration

T2I is managed and run by the NCI TTC, in partnership with the following NCI offices: SBIR Development Center, Center for Cancer Research (CCR), and Center for Cancer Training (CCT).

  • Updated:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Transition to Industry Fellowship (T2I) was originally published by the National Cancer Institute.”

Email